🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523558-14-00
Ongoing Phase I

A Phase 1 Study of AIR-001 in Adults with AATD.

2025-523558-14-00 · tracked via the Priya Life Science EU tracker
Sponsor
Airna Corp.
Sponsor type
Pharmaceutical company
Therapeutic area
Respiratory Tract Diseases
Decision date
17/04/2026
Enrollment target
19
Sites
Sweden, Ireland, Spain, Netherlands, Portugal, Germany

Condition studied

Alpha-1 Antitrypsin Deficiency

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523558-14-00 on CTIS ↗ ← All trials in the EU